|
2024-11-14 |
2024-11-11 |
V
Vente
|
Ryan Michelle R
Administrateur non-exécutif
|
2 800
-20.5%
59,70
167 160 USD
|
2 800
-20.5%
|
59,70
|
167 160 USD
|
|
|
2024-10-21 |
2024-10-18 |
V
Vente
|
Ferraro Joseph Anthony
SVP, General Counsel, CCO
Dirigeant
|
320
-1.3%
59,97
19 190 USD
|
320
-1.3%
|
59,97
|
19 190 USD
|
|
|
2024-09-27 |
2024-09-26 |
V
Vente
|
McErlane David
Group President, Biologics
Dirigeant
|
1 994
-5.2%
59,97
119 580 USD
|
1 994
-5.2%
|
59,97
|
119 580 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
666
-1.7%
59,55
39 660 USD
|
666
-1.7%
|
59,55
|
39 660 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Hopson Ricky
Pres. BioProduct Delivery, CoS
Dirigeant
|
662
-2.2%
59,56
39 429 USD
|
662
-2.2%
|
59,56
|
39 429 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Ferraro Joseph Anthony
SVP, General Counsel, CCO
Dirigeant
|
608
-2.4%
59,58
36 225 USD
|
608
-2.4%
|
59,58
|
36 225 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
1 169
-1.0%
59,55
69 614 USD
|
1 169
-1.0%
|
59,55
|
69 614 USD
|
|
|
2024-08-05 |
2024-08-02 |
V
Vente
|
Evoli Lisa
SVP, Chief HR Officer
Dirigeant
|
3 859
-8.9%
59,67
230 267 USD
|
3 859
-8.9%
|
59,67
|
230 267 USD
|
|
|
2024-07-30 |
2024-07-29 |
V
Vente
|
Hopson Ricky
Pres. BioProduct Delivery, CoS
Dirigeant
|
206
-0.7%
58,67
12 086 USD
|
206
-0.7%
|
58,67
|
12 086 USD
|
|
|
2024-07-30 |
2024-07-29 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
9 088
-4.9%
58,76
534 011 USD
|
9 088
-4.9%
|
58,76
|
534 011 USD
|
|
|
2024-07-30 |
2024-07-29 |
V
Vente
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
283
-0.7%
58,69
16 609 USD
|
283
-0.7%
|
58,69
|
16 609 USD
|
|
|
2024-07-30 |
2024-07-29 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
349
-0.3%
58,70
20 486 USD
|
349
-0.3%
|
58,70
|
20 486 USD
|
|
|
2024-07-10 |
2024-07-08 |
V
Vente
|
Masanovich Matti
SVP, Chief Financial Officer
Dirigeant
|
2 993
-8.1%
56,74
169 823 USD
|
2 993
-8.1%
|
56,74
|
169 823 USD
|
|
|
2024-06-05 |
2024-06-04 |
V
Vente
|
Hopson Ricky
Pres. BioProduct Delivery, CoS
Dirigeant
|
1 401
-6.4%
54,26
76 023 USD
|
1 401
-6.4%
|
54,26
|
76 023 USD
|
|
|
2024-03-19 |
2024-03-15 |
VP
Vente planifiée
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
387
-1.3%
56,20
21 749 USD
|
387
-1.3%
|
56,20
|
21 749 USD
|
|
|
2023-09-05 |
2023-08-31 |
A
Achat
|
Ryan Michelle R
Administrateur non-exécutif
|
1 000
+102.1%
49,98
49 980 USD
|
1 000
+102.1%
|
49,98
|
49 980 USD
|
|
|
2023-09-01 |
2023-08-30 |
A
Achat
|
GREISCH JOHN J
Executive Chair
Administrateur exécutif
|
21 000
+161.5%
50,24
1 055 040 USD
|
21 000
+161.5%
|
50,24
|
1 055 040 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.
Dirigeant
|
87
-0.2%
44,87
3 904 USD
|
87
-0.2%
|
44,87
|
3 904 USD
|
|
|
2023-08-25 |
2023-08-24 |
VP
Vente planifiée
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Dirigeant
|
276
-1.2%
44,56
12 299 USD
|
276
-1.2%
|
44,56
|
12 299 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
396
-0.4%
44,49
17 618 USD
|
396
-0.4%
|
44,49
|
17 618 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
101
-0.1%
45,15
4 560 USD
|
101
-0.1%
|
45,15
|
4 560 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
1 970
-2.2%
44,51
87 685 USD
|
1 970
-2.2%
|
44,51
|
87 685 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Lickfold Charles
SVP, CIO
Dirigeant
|
190
-1.6%
44,72
8 497 USD
|
190
-1.6%
|
44,72
|
8 497 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Dirigeant
|
147
-1.9%
44,72
6 574 USD
|
147
-1.9%
|
44,72
|
6 574 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Dirigeant
|
216
-2.4%
44,71
9 657 USD
|
216
-2.4%
|
44,71
|
9 657 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Dirigeant
|
390
-1.6%
44,50
17 355 USD
|
390
-1.6%
|
44,50
|
17 355 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
269
-0.9%
44,57
11 989 USD
|
269
-0.9%
|
44,57
|
11 989 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Hunt Patricia
Pres. Consumer Health Div
Dirigeant
|
106
-0.9%
44,77
4 746 USD
|
106
-0.9%
|
44,77
|
4 746 USD
|
|
|
2023-08-25 |
2023-08-24 |
V
Vente
|
Pravda Ricardo
Chief Transformation Officer
Dirigeant
|
379
-1.2%
44,47
16 854 USD
|
379
-1.2%
|
44,47
|
16 854 USD
|
|
|
2023-08-25 |
2023-08-24 |
VP
Vente planifiée
|
Fasman Steven L
EVP & Chief Admin Officer
Dirigeant
|
817
-1.1%
44,65
36 479 USD
|
817
-1.1%
|
44,65
|
36 479 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Fasman Steven L
EVP & Chief Admin Officer
Dirigeant
|
524
-0.9%
47,76
25 026 USD
|
524
-0.9%
|
47,76
|
25 026 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Fasman Steven L
EVP & Chief Admin Officer
Dirigeant
|
1 113
-1.8%
46,72
51 999 USD
|
1 113
-1.8%
|
46,72
|
51 999 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Lickfold Charles
SVP, CIO
Dirigeant
|
135
-2.4%
47,90
6 467 USD
|
135
-2.4%
|
47,90
|
6 467 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.
Dirigeant
|
62
-0.1%
47,80
2 964 USD
|
62
-0.1%
|
47,80
|
2 964 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Hunt Patricia
Pres. Consumer Health Div
Dirigeant
|
161
-1.7%
47,95
7 720 USD
|
161
-1.7%
|
47,95
|
7 720 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Pravda Ricardo
Chief Transformation Officer
Dirigeant
|
222
-1.1%
47,78
10 607 USD
|
222
-1.1%
|
47,78
|
10 607 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Pravda Ricardo
Chief Transformation Officer
Dirigeant
|
47
-0.2%
46,50
2 186 USD
|
47
-0.2%
|
46,50
|
2 186 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
220
-0.3%
47,87
10 531 USD
|
220
-0.3%
|
47,87
|
10 531 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
61
-0.1%
46,58
2 841 USD
|
61
-0.1%
|
46,58
|
2 841 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Dirigeant
|
258
-4.8%
47,97
12 376 USD
|
258
-4.8%
|
47,97
|
12 376 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
190
-0.8%
47,90
9 101 USD
|
190
-0.8%
|
47,90
|
9 101 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Dirigeant
|
195
-1.2%
47,86
9 333 USD
|
195
-1.2%
|
47,86
|
9 333 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Dirigeant
|
383
-7.7%
47,77
18 296 USD
|
383
-7.7%
|
47,77
|
18 296 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Dirigeant
|
241
-1.4%
47,88
11 539 USD
|
241
-1.4%
|
47,88
|
11 539 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Dirigeant
|
35
-0.2%
46,64
1 632 USD
|
35
-0.2%
|
46,64
|
1 632 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
606
-0.7%
47,75
28 937 USD
|
606
-0.7%
|
47,75
|
28 937 USD
|
|
|
2023-08-03 |
2023-08-01 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
879
-1.0%
46,71
41 058 USD
|
879
-1.0%
|
46,71
|
41 058 USD
|
|
|
2023-05-03 |
2023-05-01 |
V
Vente
|
Boerman Manja
Pres. BioModalities Division
Dirigeant
|
1 446
-9.1%
49,86
72 098 USD
|
1 446
-9.1%
|
49,86
|
72 098 USD
|
|
|
2023-05-03 |
2023-05-01 |
V
Vente
|
Gargiulo Mario
SVP, Ops, Biologics Europe
Dirigeant
|
678
-10.7%
49,86
33 805 USD
|
678
-10.7%
|
49,86
|
33 805 USD
|
|
|
2023-01-25 |
2023-01-23 |
V
Vente
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Dirigeant
|
643
-3.8%
49,36
31 738 USD
|
643
-3.8%
|
49,36
|
31 738 USD
|
|
|
2022-12-07 |
2022-12-05 |
V
Vente
|
Boerman Manja
Pres. BioModalities Division
Dirigeant
|
780
-4.7%
51,70
40 326 USD
|
780
-4.7%
|
51,70
|
40 326 USD
|
|
|
2022-11-02 |
2022-10-31 |
V
Vente
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Dirigeant
|
2 451
-12.1%
65,83
161 349 USD
|
2 451
-12.1%
|
65,83
|
161 349 USD
|
|
|
2022-10-12 |
2022-10-10 |
VP
Vente planifiée
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Dirigeant
|
930
-14.8%
77,46
72 038 USD
|
930
-14.8%
|
77,46
|
72 038 USD
|
|
|
2022-09-02 |
2022-08-31 |
VP
Vente planifiée
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Dirigeant
|
2 216
-11.5%
89,59
198 531 USD
|
2 216
-11.5%
|
89,59
|
198 531 USD
|
|
|
2022-08-30 |
2022-08-26 |
VP
Vente planifiée
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
1 639
-6.4%
104,07
170 571 USD
|
1 639
-6.4%
|
104,07
|
170 571 USD
|
|
|
2022-08-30 |
2022-08-26 |
VP
Vente planifiée
|
Riley Michael A.
Pres. Bio Product Delivery Div
Dirigeant
|
2 491
-27.4%
104,07
259 238 USD
|
2 491
-27.4%
|
104,07
|
259 238 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Gargiulo Mario
SVP Global Ops Biologics
Dirigeant
|
1 586
-20.0%
103,04
163 421 USD
|
1 586
-20.0%
|
103,04
|
163 421 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Dirigeant
|
1 670
-7.6%
103,04
172 077 USD
|
1 670
-7.6%
|
103,04
|
172 077 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
1 840
-6.7%
103,04
189 594 USD
|
1 840
-6.7%
|
103,04
|
189 594 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Castellano Thomas P
SVP, Chief Financial Officer
Dirigeant
|
1 414
-6.6%
103,04
145 699 USD
|
1 414
-6.6%
|
103,04
|
145 699 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Pravda Ricardo
SVP & Chief HR Officer
Dirigeant
|
1 747
-8.0%
103,04
180 011 USD
|
1 747
-8.0%
|
103,04
|
180 011 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Hunt Patricia
Pres. Consumer Health Div
Dirigeant
|
339
-3.5%
103,04
34 931 USD
|
339
-3.5%
|
103,04
|
34 931 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Arnold Jonathan
SVP & Chief Commercial Ofcr
Dirigeant
|
384
-0.7%
103,04
39 567 USD
|
384
-0.7%
|
103,04
|
39 567 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Dirigeant
|
1 645
-1.9%
103,04
169 501 USD
|
1 645
-1.9%
|
103,04
|
169 501 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Riley Michael A.
Pres. Bio Product Delivery Div
Dirigeant
|
1 482
-14.0%
103,04
152 705 USD
|
1 482
-14.0%
|
103,04
|
152 705 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Maselli Alessandro
President & CEO
Administrateur exécutif
|
4 646
-10.1%
103,04
478 724 USD
|
4 646
-10.1%
|
103,04
|
478 724 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Boerman Manja
Pres. BioModalities Division
Dirigeant
|
3 296
-16.5%
103,04
339 620 USD
|
3 296
-16.5%
|
103,04
|
339 620 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Chiminski John R
Executive Chair
Administrateur exécutif
|
38 934
-14.5%
103,04
4 011 759 USD
|
38 934
-14.5%
|
103,04
|
4 011 759 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Dirigeant
|
1 517
-7.3%
103,04
156 312 USD
|
1 517
-7.3%
|
103,04
|
156 312 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Dirigeant
|
671
-9.6%
103,04
69 140 USD
|
671
-9.6%
|
103,04
|
69 140 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Dirigeant
|
1 033
-17.2%
103,04
106 440 USD
|
1 033
-17.2%
|
103,04
|
106 440 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Fasman Steven L
EVP & Chief Admin Officer
Dirigeant
|
4 811
-7.2%
103,04
495 725 USD
|
4 811
-7.2%
|
103,04
|
495 725 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Schmidt Kay A
SVP, Enterprise Functions
Dirigeant
|
1 321
-7.1%
103,04
136 116 USD
|
1 321
-7.1%
|
103,04
|
136 116 USD
|
|
|
2022-07-28 |
2022-07-27 |
VP
Vente planifiée
|
Gunther Scott
SVP, Quality & Reg. Affairs
Dirigeant
|
394
-1.7%
107,67
42 422 USD
|
394
-1.7%
|
107,67
|
42 422 USD
|
|
|
2022-07-28 |
2022-07-27 |
VP
Vente planifiée
|
Hopson Ricky
Pres, Clinical Dev & Supply
Dirigeant
|
591
-3.3%
107,67
63 633 USD
|
591
-3.3%
|
107,67
|
63 633 USD
|
|
